Magnesium chloride; sodium bicarbonate; sodium chloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for magnesium chloride; sodium bicarbonate; sodium chloride and what is the scope of patent protection?
Magnesium chloride; sodium bicarbonate; sodium chloride
is the generic ingredient in two branded drugs marketed by Dialysis Sups and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Magnesium chloride; sodium bicarbonate; sodium chloride has four patent family members in four countries.
Summary for magnesium chloride; sodium bicarbonate; sodium chloride
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 241 |
| DailyMed Link: | magnesium chloride; sodium bicarbonate; sodium chloride at DailyMed |
Recent Clinical Trials for magnesium chloride; sodium bicarbonate; sodium chloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Prim. Priv. Doz. Dr. Daniel Cejka | Phase 2 |
| Medice Arzneimittel Pütter GmbH & Co KG | Phase 2 |
| University Hospital, Bordeaux | Phase 2/Phase 3 |
See all magnesium chloride; sodium bicarbonate; sodium chloride clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for magnesium chloride; sodium bicarbonate; sodium chloride
US Patents and Regulatory Information for magnesium chloride; sodium bicarbonate; sodium chloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dialysis Sups | NORMOCARB HF 25 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-001 | Jul 26, 2006 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Dialysis Sups | NORMOCARB HF 35 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-002 | Jul 26, 2006 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for magnesium chloride; sodium bicarbonate; sodium chloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dialysis Sups | NORMOCARB HF 25 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-001 | Jul 26, 2006 | See Plans and Pricing | See Plans and Pricing |
| Dialysis Sups | NORMOCARB HF 35 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-002 | Jul 26, 2006 | See Plans and Pricing | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for magnesium chloride; sodium bicarbonate; sodium chloride
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 0249693 | See Plans and Pricing | |
| Australia | 2620902 | See Plans and Pricing | |
| European Patent Office | 1347795 | See Plans and Pricing | |
| Canada | 2365787 | SOLUTIONS CONCENTREES STERILES FAIBLES EN BICARBONATE POUR DIALYSE (STERILE LOW BICARBONATE DIALYSIS CONCENTRATE SOLUTIONS) | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for magnesium chloride; sodium bicarbonate; sodium chloride
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1020461 | 300482 | Netherlands | See Plans and Pricing | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
| 0984957 | C300483 | Netherlands | See Plans and Pricing | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYFRAAT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20110524 |
| 1499331 | 122014000007 | Germany | See Plans and Pricing | PRODUCT NAME: NATRIUMSULFAT, MAGNESIUMSULFAT UND KALIUMSULFAT; NAT. REGISTRATION NO/DATE: 86203.00.00 20130808; FIRST REGISTRATION: BELGIEN BE434323 20130220 |
| 1499331 | C300615 | Netherlands | See Plans and Pricing | PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220 |
| 1499331 | SPC/GB13/034 | United Kingdom | See Plans and Pricing | PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313 |
| 1020461 | C300482 | Netherlands | See Plans and Pricing | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20101105 |
| 0984957 | 122012000017 | Germany | See Plans and Pricing | PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
